d-alpha tocopherol has been researched along with Parkinsonian Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CH; Chen, NF; Chen, WF; Feng, CW; Hsiao, CD; Huang, SY; Hung, HC; Wang, HM; Wen, ZH; Yang, SN | 1 |
| Joyce, JN; Nakadate, K; Noda, T; Sakakibara, S; Shinoda, M; Ueda, S | 1 |
| Jishage, K; Mizuno, Y; Mochizuki, H; Nishida, Y; Ren, YR; Uchihara, T; Yasuda, T; Yokota, T; Yoshimi, K | 1 |
| Behzadi, G; Roghani, M | 1 |
| Gerlach, M; Riederer, P; Sian, J | 1 |
1 review(s) available for d-alpha tocopherol and Parkinsonian Disorders
| Article | Year |
|---|---|
Is there neuroprotection in Parkinson syndrome?
Topics: Dopamine Agonists; Drug Therapy, Combination; Humans; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinsonian Disorders; Receptors, N-Methyl-D-Aspartate; Selegiline; Vitamin E | 2000 |
4 other study(ies) available for d-alpha tocopherol and Parkinsonian Disorders
| Article | Year |
|---|---|
Effects of 6-hydroxydopamine exposure on motor activity and biochemical expression in zebrafish (Danio rerio) larvae.
Topics: Animals; Antiparkinson Agents; Anxiety; Biomarkers; Blotting, Western; Carbidopa; Disease Models, Animal; Drug Combinations; Levodopa; Minocycline; Motor Activity; Oxidopamine; Parkinsonian Disorders; Real-Time Polymerase Chain Reaction; Sympatholytics; Vitamin E; Zebrafish; Zebrafish Proteins | 2014 |
Degeneration of dopaminergic neurons in the substantia nigra of zitter mutant rat and protection by chronic intake of Vitamin E.
Topics: Animals; Disease Models, Animal; Dopamine; Drug Administration Schedule; Free Radical Scavengers; Free Radicals; Genetic Predisposition to Disease; Immunohistochemistry; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Mutant Strains; Substantia Nigra; Tyrosine 3-Monooxygenase; Vitamin E | 2005 |
Genetic vitamin E deficiency does not affect MPTP susceptibility in the mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Oral; Animals; Brain; Corpus Striatum; Disease Susceptibility; Dopamine Antagonists; Genotype; Glutathione; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotoxins; Parkinsonian Disorders; Substantia Nigra; Superoxide Dismutase; Superoxide Dismutase-1; Vitamin E; Vitamin E Deficiency | 2006 |
Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence.
Topics: Amphetamine; Animals; Apomorphine; Atrophy; Axonal Transport; Corpus Striatum; Disease Models, Animal; Male; Motor Activity; Neurons; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase; Vitamin E; Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 2001 |